Veeda Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 36.44 Cr
- Paid Up Capital ₹ 12.60 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.00 Cr
- Satisfied Charges ₹ 61.26 Cr
- Revenue Growth 33.81%
- Profit Growth 41.57%
- Ebitda 32.46%
- Net Worth 10.01%
- Total Assets 10.69%
About Veeda Clinical Research
Veeda Clinical Research Limited (VCRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 23 April 2004 and has a history of 20 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Clinisearch Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 36.44 Cr and a paid-up capital of Rs 12.60 Cr.
The company currently has active open charges totaling ₹25.00 Cr. The company has closed loans amounting to ₹61.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Veeda Clinical Research Limited India are Nirmal Bhatia as Company Secretary, Ajay Tandon as Ceo, and Mahesh Bhalgat as Ceo. Nitin Deshmukh, Binoy Gardi, Kiran Marthak, and Nine other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100GJ2004PLC044023
- Company No.
044023
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2004
- Date of AGM
20 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Veeda Clinical Research Limited offer?
Veeda Clinical Research Limited offers a wide range of products and services, including Material Testing Labs & Services, Testing Services.
Who are the key members and board of directors at Veeda Clinical Research?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Bhalgat  | Managing Director | 19-Jun-2024 | Current |
Nirmal Bhatia  | Company Secretary | 26-Oct-2018 | Current |
| Ajay Tandon | CEO | 27-May-2024 | Current |
Board Members (11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Bhartia | Director | 01-Jul-2021 | Current |
| Nitin Deshmukh | Director | 01-Jul-2021 | Current |
| Jeanne Hecht | Director | 01-Jul-2021 | Current |
| Chirag Sachdev | Nominee Director | 25-May-2024 | Current |
Binoy Gardi  | Whole-Time Director | 16-May-2024 | Current |
| Kiran Marthak | Director | 06-Aug-2005 | Current |
Financial Performance of Veeda Clinical Research.
Veeda Clinical Research Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.81% increase. The company also saw a substantial improvement in profitability, with a 41.57% increase in profit. The company's net worth Soared by an impressive increase of 10.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Veeda Clinical Research?
In 2023, Veeda Clinical Research had a promoter holding of 42.07% and a public holding of 57.93%. The company had 2 Subsidiaries and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Samta Mines And Minerals LimitedNitin Deshmukh is a mutual person
Jiwa Foods Private LimitedApurva Shah is a mutual person
Aravali Securities And Finance LimitedRakesh Bhartia is a mutual person
Advy Chemical Private LimitedNitin Deshmukh is a mutual person
Zetts Cosmetics Private LimitedApurva Shah is a mutual person
Monepeak Fintech Private LimitedTanushree Agarwal is a mutual person
Charges (Loans)
₹25.00 Cr
₹61.26 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 20.00 Cr
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2022 | Others | ₹5.00 Cr | Open |
| 28 Mar 2018 | Axis Bank Limited | ₹20.00 Cr | Open |
| 29 Aug 2017 | Others | ₹2.67 Cr | Satisfied |
| 22 Dec 2016 | Tata Capital Financial Services Limited | ₹10.00 Cr | Satisfied |
| 24 Nov 2015 | Tata Capital Financial Services Limited | ₹5.00 Cr | Satisfied |
How Many Employees Work at Veeda Clinical Research?
Veeda Clinical Research has a workforce of 902 employees as of Nov 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Veeda Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veeda Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
